Bruce Lynn appointed CEO

Bruce Lynn appointed CEO

SmartTarget Ltd, a spinout of UCL (University College London) that has developed a CE-approved device for precision prostate biopsy and...

MRI Masterclass in Prostate Cancer for Urologists

SmartTarget is sponsoring the latest MRI Masterclass in prostate cancer for urologists at UCL Life Learning. This short course run by...

SmartTarget training opportunity for urological nurses

SmartTarget training opportunity for urological nurses

We are currently looking to recruit urological nurses to receive specialist training for supporting SmartTarget use in theatre for our...

SmartTarget announces product launch

London, 30th September 2016 SmartTarget Ltd announces the launch of its new device for the detection of prostate cancer. The...

Launching at BAUS16

SmartTarget Ltd are pleased to announce their CE-marked device for transperineal fusion biopsy will be formally launched as a market-ready...

1 2